SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-034358
Filing Date
2021-10-12
Accepted
2021-10-12 16:15:32
Documents
4
Period of Report
2021-11-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20000854x2_def14a.htm DEF 14A 613636
2 ny20000854x2_pc01.jpg GRAPHIC 708012
3 ny20000854x2_pc02.jpg GRAPHIC 421889
4 sig_yniihara.jpg GRAPHIC 21048
  Complete submission text file 0001140361-21-034358.txt   2199273
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35527 | Film No.: 211318746
SIC: 2834 Pharmaceutical Preparations